CF-Carvacrol

• Target:

  PPAR|||Nrf2|||Interleukin

• Related Pathways:

  Metabolism|||DNA Damage/DNA Repair|||Immunology/Inflammation

• Bioactivity:

  CF-Carvacrol is an orally active lipid-lowering agent synthesized by combining Carvacrol and Clofibric acid. It shows strong affinity for PPAR-? and demonstrates significant hypolipidemic activity. Additionally, CF-Carvacrol exerts antioxidant and anti-inflammatory effects by activating the Nrf2/HO-1 signaling pathway, thereby alleviating liver damage. This compound is applicable in research on liver injury induced by cystic fibrosis.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C